Study on pharmacokinetics of sulfamonomethoxine long-acting injection in pigs
Zhuo Qu
Abstract
Zhuo Qu
Abstract
The objective of the study was to investigate pharmacokinetic properties of sulfamonomethoxine long-acting injection in pigs. Twelve pigs were allotted to two groups at 6 pigs per group. The pigs in two groups were administered muscularly with sulfamonomethoxine long-acting injection A and sulfa- monomethoxine long-acting injection B respectively at the dose of 0.4 mL/kg body weight. Blood samples at 5 mL each time were collected from front cavity veins at different intervals after administration. The drug concentrations in plasma were analyzed by HPLC, and then the pharmacokinetic parameters were calculated by using MCPKP software. The results of the sulfamonomethoxine long-acting injection A were as follows: C_(max)=22.30 μg/mL±2.09 μg/mL, AUC=533.58 μg/(mL·h)±30.76 μg/(mL·h) and t_(1/2)_β=(20.20) h±5.31 h. The results of the sulfamonomethoxine long-acting injection B were as follows: C_(max)=15.96 μg/mL±2.36 μg/mL, AUC=199.91 μg/(mL·h)±11.31 μg/(mL·h) and t_(1/2)_β=9.81 h±1.03 h.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The objective of the study was to investigate pharmacokinetic properties of sulfamonomethoxine long-acting injection in pigs. Twelve pigs were allotted to two groups at 6 pigs per group. The pigs in two groups were administered muscularly with sulfamonomethoxine long-acting injection A and sulfa- monomethoxine long-acting injection B respectively at the dose of 0.4 mL/kg body weight. Blood samples at 5 mL each time were collected from front cavity veins at different intervals after administration. The drug concentrations in plasma were analyzed by HPLC, and then the pharmacokinetic parameters were calculated by using MCPKP software. The results of the sulfamonomethoxine long-acting injection A were as follows: C_(max)=22.30 μg/mL±2.09 μg/mL, AUC=533.58 μg/(mL·h)±30.76 μg/(mL·h) and t_(1/2)_β=(20.20) h±5.31 h. The results of the sulfamonomethoxine long-acting injection B were as follows: C_(max)=15.96 μg/mL±2.36 μg/mL, AUC=199.91 μg/(mL·h)±11.31 μg/(mL·h) and t_(1/2)_β=9.81 h±1.03 h.
Key concepts: Pharmacokinetics, High-performance liquid chromatography, Pharmacology, Plasma concentration, Body weight, Chemistry, Chromatography, Medicine